Gregory D. Perry

Insider Reports History

Entity
Individual
Location
C/O Immunogen, Inc., 830 Winter St., Waltham, MA
Signature
/s/ Mary Reumuth, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Gregory D. Perry:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Merus N.V. Chief Financial Officer & PFO Share Option (right to buy) 107K $1.45M $13.52 May 7, 2024 Direct
KALA BIO, Inc. Director Common Stock 10.9K $66.3K $6.09 Jun 11, 2024 Direct
Finch Therapeutics Group, Inc. Chief Financial Officer Employee Stock Option (right to buy) 80K Feb 25, 2022 Direct
KALA BIO, Inc. Director Stock Option (right to buy) 3.15K Jun 11, 2024 Direct

Insider Reports Filed by Gregory D. Perry

Symbol Company Period Transactions Value $ Form Type Date Filed Role
KALA KALA BIO, Inc. Jun 11, 2024 2 $0 4 Jun 12, 2024 Director
MRUS Merus N.V. May 7, 2024 1 $0 4 May 9, 2024 Chief Financial Officer & PFO
KALA Kala Pharmaceuticals, Inc. Jun 22, 2023 4 $0 4 Jun 23, 2023 Director
MRUS Merus N.V. Jun 14, 2023 1 $0 4 Jun 15, 2023 Chief Financial Officer
MRUS Merus N.V. Jun 8, 2023 1 $0 4 Jun 12, 2023 Director
KALA Kala Pharmaceuticals, Inc. May 31, 2023 4 $0 4 Jun 2, 2023 Director
KALA Kala Pharmaceuticals, Inc. Jun 16, 2022 1 $0 4 Jun 17, 2022 Director
MRUS Merus N.V. May 31, 2022 1 $0 4 Jun 2, 2022 Director
FNCH Finch Therapeutics Group, Inc. Feb 25, 2022 1 $0 4 Feb 28, 2022 Chief Financial Officer
KALA Kala Pharmaceuticals, Inc. Jun 17, 2021 1 $0 4 Jun 21, 2021 Director
MRUS Merus N.V. May 28, 2021 1 $0 4 Jun 2, 2021 Director